Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator

Description

Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.

Conditions

Heart Failure

Talk to us

Study Overview

On this page

Study Details

Study overview

Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.

Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator

Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator

Condition
Heart Failure
Intervention / Treatment

-

Contacts and Locations

Rochester

MAYO Clinic, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age or older
  • * heart failure or a history of heart failure
  • * ischemic or non-ischemic cardiomyopathy
  • * ejection Fraction less than or equal to 40% as measured within the last 6 months
  • * implanted left ventricular assist device
  • * pacemaker dependency
  • * currently hospitalized
  • * atrial fibrillation on their last ECG or having an irregularly irregular pulse

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Zoll Medical Corporation,

Mike Osz, STUDY_DIRECTOR, Director, Clinical Operations, ZOLL

Study Record Dates

2025-03-31